| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |